SCOPUS 정보 검색 플랫폼

Arthritis and Rheumatism

Volumn 46, Issue 3, 2002, Pages 574-578

Targeting interleukin-1 in the treatment of rheumatoid arthritis

(2) Dayer, Jean Michel a Bresnihan, Barry b

a UNIVERSITY HOSPITAL (Switzerland)

b ST VINCENT S UNIVERSITY HOSPITAL (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECANASE; APOLIPOPROTEIN A1; BETA2 INTEGRIN; CASPASE; CD69 ANTIGEN; COLLAGEN; CYTOKINE; ETANERCEPT; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; METHOTREXATE; PLACEBO; PROSTAGLANDIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA;

BINDING SITE; CHEMICAL INTERACTION; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISABILITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; INJECTION SITE; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOCYTE ACTIVATION; MONOCYTIC LEUKEMIA; MONOTHERAPY; NONHUMAN; OSTEOLYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RECEPTOR BINDING; RHEUMATOID ARTHRITIS; SKIN MANIFESTATION; TREATMENT OUTCOME;

ARTHRITIS, RHEUMATOID; HUMANS; INTERLEUKIN-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036188765 PISSN: 00043591 EISSN: None Source Type: Journal
DOI: 10.1002/art.10168 Document Type: Editorial

Times cited : (88)

References (26)

1
- 0000066854
- Cytokines and growth factors
- Kelley WN, Harris ED, Ruddy S, Sledge CB, editors. Philadelphia: WB Saunders
- (1997) Textbook of Rheumatology. 5th ed. , pp. 267-286
- Dayer, J.-M.¹ Arend, W.P.²

2
- 0033281731
- Cytokines and direct cell contact in synovitis: Relevance to therapeutic intervention
- (1999) Arthritis Res , vol.1 , pp. 17-20
- Dayer, J.-M.¹ Burger, D.²

3
- 0035871793
- Apolipoprotein A-I inhibits the production of interleukin-1β and tumor necrosis factor-α by blocking contact-mediated activation of monocytes by T lymphocytes
- (2001) Blood , vol.97 , pp. 2381-2389
- Hyka, N.¹ Dayer, J.-M.² Modoux, C.³ Kohno, T.⁴ Edwards III, C.K.⁵ Roux-Lombard, P.⁶

4
- 0029979369
- Biologic basis for interleukin-1 in disease
- (1996) Blood , vol.87 , pp. 2095-2147
- Dinarello, C.A.¹

5
- 0023617050
- A urine inhibitor of interleukin 1 activity that blocks ligand binding
- (1987) J Immunol , vol.139 , pp. 1546-1549
- Seckinger, P.¹ Lowenthal, J.W.² Williamson, K.³ Dayer, J.-M.⁴ MacDonald, H.R.⁵

6
- 0022930042
- Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s)
- (1986) J Clin Invest , vol.78 , pp. 1120-1124
- Balavoine, J.-F.¹ De Rochemonteix, B.² Williamson, K.³ Seckinger, P.⁴ Cruchaud, A.⁵ Dayer, J.-M.⁶

7
- 0023241974
- Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis
- (1987) Lancet , vol.2 , pp. 1240-1242
- Prieur, A.-M.¹ Kaufman, M.-T.² Griscelli, C.³ Dayer, J.-M.⁴

8
- 0021844572
- Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor
- (1985) J Immunol , vol.13 , pp. 3868-3875
- Arend, W.P.¹ Joslin, F.G.² Massoni, R.J.³

9
- 0025713953
- Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
- (1990) Nature , vol.343 , pp. 336-340
- Hannum, C.H.¹ Wilcox, C.J.² Arend, W.P.³ Joslin, F.G.⁴ Dripps, D.J.⁵ Heimdal, P.L.⁶

10
- 0025021471
- Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist
- (1990) Nature , vol.343 , pp. 341-346
- Eisenberg, S.P.¹ Evans, R.J.² Arend, W.P.³ Verderber, E.⁴ Brewer, M.T.⁵ Hannum, C.H.⁶

11
- 0029145145
- The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor
- (1995) J Clin Invest , vol.96 , pp. 38-41
- Burger, D.¹ Chicheportiche, R.² Giri, J.³ Dayer, J.-M.⁴

12
- 0025614619
- Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production
- (1990) J Immunol , vol.145 , pp. 4181-4184
- Seckinger, P.¹ Klein-Nulend, J.² Alander, C.³ Thompson, R.C.⁴ Dayer, J.-M.⁵ Raisz, L.G.⁶

13
- 0035306510
- Uncoupling of inflammatory and destructive mechanisms in arthritis
- (2001) Semin Arthritis Rheum , vol.30 , Issue.SUPPL. 2 , pp. 7-16
- Van den Berg, W.B.¹

14
- 0034677123
- Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice
- (2000) J Exp Med , vol.191 , pp. 313-320
- Horai, R.¹ Saijo, S.² Tanioka, H.³ Nakae, S.⁴ Sudo, K.⁵ Okahara, A.⁶

15
- 0034677174
- Arterial inflammation in mice lacking the interleukin-1 receptor antagonist gene
- (2000) J Exp Med , vol.191 , pp. 303-312
- Nicklin, M.J.¹ Hughes, D.E.² Barton, J.L.³ Ure, J.M.⁴ Duff, G.W.⁵

16
- 0033666905
- Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting
- (2000) J Am Coll Cardiol , vol.36 , pp. 2168-2173
- Kastrati, A.¹ Koch, W.² Berger, P.B.³ Mehilli, J.⁴ Stephenson, K.⁵ Neumann, F.J.⁶

17
- 0036190776
- Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate
- (2002) Arthritis Rheum , vol.46 , pp. 614-624
- Cohen, S.¹ Hurd, E.² Cush, J.³ Schiff, M.⁴ Weinblatt, M.E.⁵ Moreland, L.W.⁶

18
- 0029044362
- American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis
- (1995) Arthritis Rheum , vol.38 , pp. 727-735
- Felson, D.T.¹ Anderson, J.J.² Boers, M.³ Bombardier, C.⁴ Furst, D.⁵ Goldsmith, C.⁶

19
- 0031680201
- Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures rather than twenty percent?
- (1998) Arthritis Rheum , vol.41 , pp. 1564-1570
- Felson, D.T.¹ Anderson, J.J.² Lange, M.L.M.³ Wells, G.⁴ LaValley, M.P.⁵

20
- 0034735842
- Infliximab and methotrexate in the treatment of rheumatoid arthritis
- (2000) N Engl J Med , vol.343 , pp. 1594-1602
- Lipsky, P.¹ Van der Heijde, D.M.F.M.² St. Clair, E.W.³ Furst, D.E.⁴ Breedveld, F.C.⁵ Kalden, J.R.⁶

21
- 0033611472
- A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
- (1999) N Engl J Med , vol.340 , pp. 253-259
- Weinblatt, M.E.¹ Kremer, J.M.² Bankhurst, A.D.³ Bulpitt, K.J.⁴ Fleischmann, R.M.⁵ Fox, R.I.⁶

22
- 17444394445
- Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
- (1998) Arthritis Rheum , vol.41 , pp. 2196-2204
- Bresnihan, B.¹ Alvaro-Gracia, J.M.² Cobby, M.³ Doherty, M.⁴ Domljan, Z.⁵ Emery, P.⁶

23
- 0034735827
- A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
- (2000) N Engl J Med , vol.343 , pp. 1586-1593
- Bathon, J.M.¹ Martin, R.W.² Fleischmann, R.M.³ Tesser, J.R.⁴ Schiff, M.H.⁵ Keystone, E.C.⁶

24
- 0031660364
- Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
- (1998) Arthritis Rheum , vol.41 , pp. 1552-1563
- Maini, R.N.¹ Breedveld, F.C.² Kalden, J.R.³ Smolen, J.S.⁴ Davis, D.⁵ Macfarlane, J.D.⁶

25
- 0018882143
- Measurement of patient outcome in arthritis
- (1980) Arthritis Rheum , vol.23 , pp. 137-145
- Fries, J.F.¹ Spitz, P.W.² Kraines, R.G.³ Holman, H.R.⁴

26
- 0034083128
- A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: Radiologic progression and correlation of Genant and Larsen scores
- (2000) Arthritis Rheum , vol.43 , pp. 1001-1009
- Jiang, Y.¹ Genant, H.K.² Watt, I.³ Cobby, M.⁴ Bresnihan, B.⁵ Aitchison, R.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.